Loading
We have very little insider data for Pozen Inc /NC so far: the most recent filing dates from 9 February 2016. With so few records, no pattern can be drawn yet. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
FY ended December 2013 · cache
7 of 7 declarations
POZEN INC is a North Carolina-based company focused on developing treatments for chronic diseases. It is listed on NASDAQ under the symbol POZN.
| Fiscal year end | Revenue | Net income | Diluted EPS | Filing |
|---|---|---|---|---|
| Dec 2013 | 10.3 m USD | -16.7 m USD | -0.55 USD | 10-K |
| Dec 2012 | 5.3 m USD | -25.3 m USD | -0.84 USD | 10-K |
| Dec 2011 | 87.0 m USD | 42.3 m USD | 1.40 USD | 10-K |
| Dec 2010 | 68.5 m USD | 23.1 m USD | 0.76 USD | 10-K |
| Dec 2009 | 32.2 m USD | -6.9 m USD | -0.23 USD | 10-K |
Amounts in USD, as filed (forms 10-K, 20-F or 40-F). Source: SEC EDGAR.